GSK, MedTrust Online launch clinical trials iPhone app

Share this article:
GSK, MedTrust Online launch clinical trials iPhone app
GSK, MedTrust Online launch clinical trials iPhone app

GlaxoSmithKline and physician portal MedTrust Online have launched a geolocating iPhone app that lets docs look up cancer clinical trials for their patients.

The free CancerTrials App offers a quick search menu based on 12 common cancers and more advanced features that refine searches based on age, gender, trial status and other criteria. Relevant trials can be mapped relative to the location of the device.

The app draws on MedTrust Online's proprietary databases of oncology info at Oncocentric.com. Android and Blackberry versions are in the works.

“Our community of oncologists continues to ask for information about the latest therapies in a format that fits their busy schedule,” said Dr. Leo Otake, VP of medical informatics at MedTrust, in a release. “This joint development with GSK Oncology has resulted in yet another effective electronic tool that empowers our users and brings cancer doctors closer to their patients.”

“GSK Oncology has always been interested in providing doctors and their patients with the access to the right information about the best therapies that improve patient outcomes,” said GSK Oncology VP, medicine development leader Jeffrey Bloss, MD. “We are pleased to work with MedTrust Online to bring simple yet highly effective information-based solutions to the cancer community.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...